U.S. markets open in 6 hours 3 minutes
  • S&P Futures

    4,128.50
    +2.00 (+0.05%)
     
  • Dow Futures

    33,740.00
    +37.00 (+0.11%)
     
  • Nasdaq Futures

    13,760.25
    -34.00 (-0.25%)
     
  • Russell 2000 Futures

    2,194.30
    +10.30 (+0.47%)
     
  • Crude Oil

    62.61
    +0.17 (+0.27%)
     
  • Gold

    1,788.00
    +9.60 (+0.54%)
     
  • Silver

    26.17
    +0.33 (+1.26%)
     
  • EUR/USD

    1.2021
    -0.0020 (-0.17%)
     
  • 10-Yr Bond

    1.5620
    0.0000 (0.00%)
     
  • Vix

    18.68
    +1.39 (+8.04%)
     
  • GBP/USD

    1.3921
    -0.0016 (-0.12%)
     
  • USD/JPY

    108.0630
    -0.0070 (-0.01%)
     
  • BTC-USD

    55,689.89
    +838.27 (+1.53%)
     
  • CMC Crypto 200

    1,276.83
    +42.42 (+3.44%)
     
  • FTSE 100

    6,886.28
    +26.41 (+0.38%)
     
  • Nikkei 225

    28,508.55
    -591.83 (-2.03%)
     

Repligen Corporation to Present at Barclays Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
Repligen Corporation
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

WALTHAM, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the Barclays Global Healthcare Conference being held March 9-11. Jon Snodgres, Chief Financial Officer, will participate in a fireside chat on Wednesday, March 10, at 1:50 p.m. EST.

A live webcast of the discussion will be accessible through the Investor Relations section of the Company’s website, and will be available for replay for a limited period of time following the conference event.

About Repligen Corporation

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Our primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of our manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. we have sites in Estonia, Germany, Ireland, the Netherlands and Sweden.

Repligen Contact:
Sondra S. Newman
Global Head of Investor Relations
(781) 419-1881
investors@repligen.com